Senzime AB (SEZI) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.091x

Based on the latest financial reports, Senzime AB (SEZI) has a cash flow conversion efficiency ratio of -0.091x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-27.69 Million ≈ $-2.98 Million USD) by net assets (Skr304.46 Million ≈ $32.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Senzime AB - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Senzime AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Senzime AB balance sheet liabilities for a breakdown of total debt and financial obligations.

Senzime AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Senzime AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Yew Lee Pacific Group Berhad
KLSE:0248
0.009x
Cheng Fwa Industrial Ltd
TWO:5426
0.017x
Ispire Technology Inc. Common Stock
NASDAQ:ISPR
0.518x
Farmsco
KO:036580
-0.006x
Highland Copper Company Inc.
V:HI
-0.087x
Ibkimyoung Co. Ltd
KQ:339950
0.107x
Progress-Werk Oberkirch AG
XETRA:PWO
0.024x
Space Shuttle Hi-Tech Co Ltd
TW:2440
-0.127x

Annual Cash Flow Conversion Efficiency for Senzime AB (2006–2025)

The table below shows the annual cash flow conversion efficiency of Senzime AB from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see SEZI company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr304.46 Million
≈ $32.76 Million
Skr-109.10 Million
≈ $-11.74 Million
-0.358x -16.98%
2024-12-31 Skr345.86 Million
≈ $37.22 Million
Skr-105.94 Million
≈ $-11.40 Million
-0.306x -0.97%
2023-12-31 Skr375.48 Million
≈ $40.41 Million
Skr-113.91 Million
≈ $-12.26 Million
-0.303x +41.91%
2022-12-31 Skr261.90 Million
≈ $28.18 Million
Skr-136.78 Million
≈ $-14.72 Million
-0.522x +3.31%
2021-12-31 Skr150.58 Million
≈ $16.20 Million
Skr-81.33 Million
≈ $-8.75 Million
-0.540x -225.94%
2020-12-31 Skr231.35 Million
≈ $24.90 Million
Skr-38.34 Million
≈ $-4.13 Million
-0.166x +0.04%
2019-12-31 Skr163.69 Million
≈ $17.62 Million
Skr-27.14 Million
≈ $-2.92 Million
-0.166x -56.49%
2018-12-31 Skr167.41 Million
≈ $18.02 Million
Skr-17.73 Million
≈ $-1.91 Million
-0.106x -21.04%
2017-12-31 Skr140.46 Million
≈ $15.12 Million
Skr-12.29 Million
≈ $-1.32 Million
-0.088x -15.36%
2016-12-31 Skr131.87 Million
≈ $14.19 Million
Skr-10.00 Million
≈ $-1.08 Million
-0.076x +45.81%
2015-12-31 Skr45.81 Million
≈ $4.93 Million
Skr-6.41 Million
≈ $-690.18K
-0.140x -60.40%
2014-12-31 Skr44.08 Million
≈ $4.74 Million
Skr-3.85 Million
≈ $-414.05K
-0.087x +39.78%
2013-12-31 Skr37.46 Million
≈ $4.03 Million
Skr-5.43 Million
≈ $-584.31K
-0.145x +23.55%
2012-12-31 Skr31.99 Million
≈ $3.44 Million
Skr-6.06 Million
≈ $-652.57K
-0.190x -170.80%
2011-12-31 Skr27.87 Million
≈ $3.00 Million
Skr-1.95 Million
≈ $-209.94K
-0.070x +27.67%
2010-12-31 Skr21.90 Million
≈ $2.36 Million
Skr-2.12 Million
≈ $-228.10K
-0.097x -0.30%
2009-12-31 Skr16.61 Million
≈ $1.79 Million
Skr-1.60 Million
≈ $-172.54K
-0.096x -664.63%
2006-12-31 Skr7.55 Million
≈ $812.29K
Skr129.00K
≈ $13.88K
0.017x --

About Senzime AB

ST:SEZI Sweden Medical Devices
Market Cap
$80.11 Million
Skr744.41 Million SEK
Market Cap Rank
#20041 Global
#355 in Sweden
Share Price
Skr4.74
Change (1 day)
+1.83%
52-Week Range
Skr4.10 - Skr7.27
All Time High
Skr26.50
About

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive … Read more